The results from a wave of medulloblastoma genome-sequencing studies revealed that DDX3X is the second most frequently mutated gene in medulloblastoma (8%, 25/300), followed by CTNNB1 (β-catenin). The gene discussed is CTNNB1; the disease is medulloblastoma.